CapsoVision (CV) Cash & Equivalents (2024 - 2026)
CapsoVision (CV) posted Cash & Equivalents of $10.1 million for Q4 2025, down 43.15% sequentially from $17.8 million in Q3 2025, and up 8.51% YoY from $9.3 million in Q4 2024.
CapsoVision (CV) Cash & Equivalents (2024 - 2026) Analysis & Trends
CapsoVision has reported Cash & Equivalents for 2 years, with the latest figure at $10.1 million in Q4 2025.
- Quarterly Cash & Equivalents rose 8.51% year-over-year to $10.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.1 million (up 8.51% YoY) and the FY2025 annual result came in at $10.1 million, up 8.51% from the prior year.
- Cash & Equivalents fell to $10.1 million in Q4 2025 per CV's latest filing, from $17.8 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $17.8 million in Q3 2025 and troughed at $1.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 482.30 Mn |
| 10 | CapsoVision | 299.87 Mn | 290.80 Mn | 1.87 Mn | 9.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.08 Mn |
| Dec 31, 2025 | 10.11 Mn |
| Sep 30, 2025 | 17.79 Mn |
| Jun 30, 2025 | 1.07 Mn |
| Dec 31, 2024 | 9.32 Mn |